Australian innovation could solve ‘urgent unmet need’ for 463 million people worldwide

A world-first Australian innovation could solve an urgent unmet need for 463 million people living with diabetes worldwide.

Up to 60 per cent of people with Type 1 diabetes and 67 per cent of those with Type 2 diabetes do not monitor blood glucose as often as recommended, with ‘fear of needles and pain of finger-pricking’ as the major reasons for reduced self-monitoring of blood glucose, the paper reports.

The Australian-invented Saliva Glucose Biosensor is the world’s first non-invasive replacement for finger-prick blood glucose testing.

ISO testing has shown the Saliva Glucose Biosensor can accurately monitor glucose levels in saliva at concentrations 100 times lower than levels detected in blood by other glucose monitoring devices.

New data released by the International Diabetes Federation (IDF) for World Diabetes Day 2019 on November 14, reports that 463 million people are currently living with diabetes globally – 25 million more people than was predicted by the IDF in 2010 for the year 2025.

You may also like 91% of clinicians use reprints to improve patient care

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.